4-methyl-2-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)aniline, 95.0%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3,3-dimethylbutanoic acid, 97.0%, 5g

DEPC, 25 ml, glass

N-[4-(2,4,6-TRIMETHYLPHENYL)-2-THIAZOLYL]-4-PYRIDINECARBOXAMIDE, 97.0%, 50mg

biphenyl-2,4,4'-triamine, 100mg

Benzyl Glycolate>98.0%(GC)5g

4-Bromonaphthalene-1-sulfonamide, 95%, 25g

2-Methoxy-n-(2,2,2-trifluoroethyl)aniline, 95%, 500mg

1-Butylcyclopropane-1-carboxylic acid, 98%, 250mg

3-BROMO-5-METHYLIMIDAZO[1,2-A]PYRAZINE, 95.0%, 250mg

Metamifop>98.0%(HPLC)(T)200mg

Silanol terminated polydimethylsiloxanes cSt 50,000, 100g

5-(Hydroxymethyl)pyridin-3-ol, 98%, 1g